Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Modulation of THC Effects by CBD: a Dose-ranging Study — Stella

Home/Cannabis/Modulation of THC Effects by CBD: a Dose-ranging Study

View on ClinicalTrials.gov

Recruiting

Back to Cannabis trials

Modulation of THC Effects by CBD: a Dose-ranging Study

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Canada

Centre de recherche du Centre Hospitalier Universitaire de Montréal, Montreal, Quebec

Key details

Phase

Early testing / Safety & dosing

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment target

~100 participants

Started

June 2024

Primary completion

July 2026

Age range

21 Years – 49 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.